A detailed history of Quest Partners LLC transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 46,002 shares of ANVS stock, worth $201,028. This represents 0.03% of its overall portfolio holdings.

Number of Shares
46,002
Holding current value
$201,028
% of portfolio
0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$5.27 - $15.46 $242,430 - $711,190
46,002 New
46,002 $371 Million
Q1 2024

May 09, 2024

BUY
$8.47 - $18.93 $28,289 - $63,226
3,340 New
3,340 $39.7 Million

Others Institutions Holding ANVS

About Annovis Bio, Inc.


  • Ticker ANVS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,163,920
  • Market Cap $35.7M
  • Description
  • Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...
More about ANVS
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.